Sell the difference – Why differentiation matters in men’s health

Mind the gap

A recent global report found that urology markets are becoming increasingly saturated, with every major device category now featuring multiple established players. At the same time, a wave of new entrants and copycat technologies is compounding the problem, creating a landscape where products often share similar designs, claims and workflows. For clinicians, it’s becoming harder to distinguish meaningful differences; for brands, it means commoditisation is the default unless they can articulate a clearer, more compelling value story. Efficacy isn’t enough - differentiation has to come from insight, narrative and lasting partnership.

Spoilt for choice

Although commoditisation isn’t unique to urology, the sector is particularly challenging because it spans so many subspecialties, each with its own expanding ecosystem of devices. Industry analyses regularly note that categories such as stone management and benign prostatic hyperplasia (BPH) now feature a growing mix of global leaders actively competing against each other and newer entrants. This breadth creates a distinct pressure: clinicians are navigating more choices than ever, often across overlapping technologies that appear comparable on paper. In this climate, even strong technologies risk being lost in the crowd simply because decision‑makers are managing too many options at once.

Spot the difference

The pressure doesn’t stop at choice overload. In several urology categories, once a technology gains traction, similar solutions tend to follow quickly. This is particularly notable in areas such as stone management and BPH, where established techniques often prompt a wave of devices built around comparable principles, workflows or claims. Soon enough, competitive clusters form, with new entrants positioning themselves close to recognised products rather than introducing something fundamentally different. This pattern doesn’t just add to the volume of options clinicians must weigh; it actively compresses the space between them, accelerating the drift towards commoditisation and reducing the impact of genuine innovation.

The full package

As differentiation at the product level becomes harder to sustain, many clinical and procurement teams are placing greater emphasis on the support that surrounds a device. Hospitals under pressure to increase throughput, reduce variation and improve financial performance are looking for partners who can help them run more efficient services, not just supply kit. This shift is reflected across multiple urology pathways, where service models, training provision, data insights and operational support are increasingly cited as factors that influence adoption. Brands that know how to present these wrap‑around elements as genuine value-adds stand to gain an advantage that cut-price rivals can’t quickly mimic. And it’s this edge that lets clinicians and procurement teams know they’re dealing with a truly invested partner.

Tell it well

With the urology market becoming more crowded and less clearly defined, brands need more than technology to rise above commoditisation, and marketers need more than a design agency – they need an experienced partner capable of delivering insight‑led storytelling, sharper value articulation and bold creatives that cut through.

‍

Ready to work with a partner who gets it - and gets it done? Let’s talk